SCHEMBL901386

SCHEMBL901386

O=C1OC(=O)C2CCCC=C12

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2356347 1.00 MAPT (0.33) MAPT
SCHEMBL2241169 1.00 MAPT (0.33) MAPT
SCHEMBL6009068 0.88
SCHEMBL15399672 0.74 PTPN1 (0.31) MAPT
SCHEMBL8463660 0.69
SCHEMBL9812339 0.69
Acrylic Acid Methyl Ester SCHEMBL8155436 0.69
SCHEMBL7325221 0.68
SCHEMBL950887 0.65 PTPN1 (0.39) MAPT
SCHEMBL2238959 0.65 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116514804-A Cathepsin K inhibitor, preparation method and application thereof 山东新时代药业有限公司 2023-08-01 CN claimed
CN-116377727-A Laser stealth coating for fabric and application method thereof 西京学院 2023-07-04 CN claimed
CN-115322398-A Polyimide fine particles 施乐公司 2022-11-11 CN claimed
US-9695149-B2 1,2,6-substituted benzimidazoles as flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-07-04 US claimed
US-20160039790-A1 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-02-11 US claimed
WO-2014151380-A1 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-09-25 WO claimed
CN-103881088-A Responsive polymeric micelle drug carrying system and preparation method thereof CHANGCHUN APPLIED CHEMISTRY 2014-06-25 CN claimed
WO-2014020570-A2 A METHOD FOR PRODUCING FIBER REINFORCED RUBBER COMPRISING UNSATURATED BONDS KORDSA GLOBAL ENDUSTRIYEL IPLIK VE KORD BEZI SANAYI VE TICARET ANONIM SIRKETI (TR) 2014-02-06 WO claimed
CN-100519630-C Active energy line cured resin, optical solidified and thermosetting resin composition containing the resin and condensate thereof TAIYO INK MFG CO LTD (JP) 2009-07-29 CN claimed
CN-1926174-A Active energy ray-curable resin, photocurable and thermosetting resin composition containing the same, and cured product thereof TAIYO INK MFG CO (JP) 2007-03-07 CN claimed
EP-0755914-B1 Process for producing isobenzofurandiones BAYER AG (DE) 1999-10-06 EP claimed
US-5672719-A Process for the preparation of isobenzofurandiones BAYER AKTIENGESELLSCHAFT (DE) 1997-09-30 US claimed
EP-0755914-A1 Process for producing isobenzofurandiones BAYER AG (DE) 1997-01-29 EP claimed
US-5030668-A Including an epoxy compound to improve the anaerobic heat resistance; glass fibers having a polyurethane coating; molding materials E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-07-09 US claimed
US-4857661-A Bicyclic keto-acids preparation TEXACO INC. (US) 1989-08-15 US claimed
EP-0281148-A2 Stabilized glass reinforced polyacetal compositions E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-09-07 EP claimed
US-4624682-A BICYCLIC KETO-AMIDES TEXACO INC. (US) 1986-11-25 US claimed
JP-9031070-A None JP disclosed
US-4009278-A Antimicrobial composition and method containing N-(3,5-dihalophenyl)-imide compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-02-22 US disclosed
US-3981827-A FIREPROOFING UNION CARBIDE CORPORATION (US) 1976-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039790-A1 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS FEN1, FOXM1, F12 MAPT 4740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.